Insiders Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Market Closed - Nasdaq Other stock markets 21:00:00 08/05/2024 BST			5-day change	1st Jan Change
0.92 ^USD	-3.82%		-4.02%	-51.32%

05-08	Transcript : Bionano Genomics, Inc., Q1 2024 Earnings Call, May 08, 2024
05-08	Bionano Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bionano Genomics Names Gulsen Kama as Finance Chief, Suceeding Christopher Stewart	14/08/23	MT
Bionano Genomics, Inc. Announces Resignation of Richard Shippy as Chief Business Officer	18/11/22	CI
Bionano Genomics, Inc. Appoints Donna Polizio as Global Head of Market Access	10/11/22	CI
Bionano Genomics, Inc. Appoints Dr. Aleks Rajkovic to Its Board of Directors	07/03/22	CI
Bionano Genomics, Inc. Appoints Aleksandar Rajkovic as Class III Director	23/02/22	CI
Bionano Genomics, Inc. Appoints Vince Wong to Board of Directors	23/12/21	CI
Bionano Genomics, Inc. Appoints Richard Shippy as its Chief Business Officer	14/06/21	CI
Bionano Genomics, Inc. Appoints Jason Priar as its Chief Commercial Officer	07/06/21	CI
Bionano Genomics, Inc. Announces Executive Changes, Effective September 1, 2020	26/08/20	CI
Bionano Genomics Appoints Christopher Stewart as Its Chief Financial Officer, Effective September 1, 2020	26/08/20	CI
Bionano Genomics, Inc. Appoints Alka Chaubey as Chief Medical Officer, Effective August 31, 2020	18/08/20	CI
Bionano Genomics, Inc. Announces Resignation of Warren Robinson as Chief Commercial Officer, Effective June 19, 2020	19/06/20	CI
Bionano Genomics, Inc. Announces Board Appointments	18/06/20	CI
Bionano Genomics, Inc. Announces Board Changes	04/05/20	CI
Bionano Genomics, Inc. Announces Resignation of Quan Zhou from the Board of Directors, Effective December 12, 2019	06/12/19	CI
Bionano Genomics, Inc. Announces the Resignation of Mike Ward as Chief Financial Officer, Effective December 6, 2019	27/11/19	CI
Bionano Genomics, Inc Announces Resignation of Darren Cai from the Board of Directors	22/08/19	CI
Bionano Genomics, Inc. Appoints Kristiina Vuori as Class II Director	11/06/19	CI
BioNano Genomics, Inc. Announces Executive Changes	08/09/16	CI
BioNano Genomics, Inc. Appoints Terry Salyer as Chief Commercial Officer	26/03/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Bionano Genomics, Inc.

Equities

BNGO

US09075F3055

Insiders

Filters